logo

Insmed Inc (INSM)



Trade INSM now with
  Date
  Headline
2/25/2020 7:36:51 AM Insmed Q4 GAAP Net Loss $53.0 Mln Or $0.59/Shr Vs GAAP Net Loss $91.6 Mln Or $1.19/Shr Last Year
2/3/2020 7:35:44 AM Insmed Announces Positive Top-Line Results From Phase 2 WILLOW Study Of INS1007
1/30/2020 8:14:29 AM Insmed Inc. Says Appoints Sara Bonstein As CFO, Effective Jan. 31, 2020
11/14/2019 8:03:19 AM Insmed Appoints Clarissa Desjardins To Board; Names Roger Adsett COO
10/30/2019 7:41:09 AM Insmed Q3 Net Loss $60.7 Mln Or $0.68/shr Vs. Net Loss $87.7 Mln Or $1.14/shr Last Year
8/1/2019 7:40:07 AM Insmed Q2 Net Loss $66.5 Mln Vs. Net Loss $76.4 Mln Last Year
7/2/2019 4:06:34 PM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
6/26/2019 5:02:57 PM Insmed Announces Closing Of Public Offering Of Common Stock
5/24/2019 11:59:39 AM Insmed Announces Closing Of Public Offering Of Common Stock
5/20/2019 4:06:30 PM Insmed Announces Proposed Public Offering Of Common Stock
5/7/2019 7:39:10 AM Insmed Q1 Net Loss $74.2 Mln Or $0.96/Shr Vs Loss Of $68.5 Mln Or $0.89/Shr Last Year
4/8/2019 5:01:44 AM Insmed Provides Update On ARIKAYCE U.S. Launch
4/2/2019 4:08:50 PM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2/22/2019 7:39:48 AM Insmed Q4 Net Loss $91.6 Mln Or $1.19/Shr Vs Loss Of $65.4 Mln Or $0.85/Shr Last Year
11/8/2018 8:35:01 AM Insmed Announces Several Changes To Board; Donald Hayden Steps Down As Chairman
10/30/2018 7:39:05 AM Insmed Q3 Net Loss $87.7 Mln Or $1.14/shr Vs. Net Loss $45.2 Mln Or $0.69/shr Last Year
  
 
>